|
Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplantation in severe aplastic anemia
|
Jul 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up
|
Mar 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?
|
Jun 2014
|
Cell Stem Cell
|
myelodysplastic syndromes (MDS)
|
|
Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes
|
Mar 2016
|
Cancer
|
myelodysplastic syndromes (MDS)
|
|
Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes
|
Feb 2014
|
Cancer
|
myelodysplastic syndromes (MDS)
|
|
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes
|
Nov 2019
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron
|
May 2014
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Aug 2016
|
Oncotarget
|
myelodysplastic syndromes (MDS)
|
|
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes
|
Oct 2019
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
|
Sep 2012
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
